SCOPUS 정보 검색 플랫폼

Volumn 17, Issue 9-10, 2012, Pages 407-408

Can efficient delivery systems leverage benefits of antioxidants leading to potential medicines?

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ELLAGIC ACID; EPIGALLOCATECHIN GALLATE; NANOPARTICLE; UBIDECARENONE;

DRUG DELIVERY SYSTEM; EDITORIAL; HUMAN; HYPERTENSION; NANOTECHNOLOGY; NONHUMAN; RENOVASCULAR HYPERTENSION;

ANTIOXIDANTS; DIET; DIETARY SUPPLEMENTS; DRUG DELIVERY SYSTEMS; HUMANS;

EID: 84860693538 PISSN: 13596446 EISSN: 18785832 Source Type: Journal
DOI: 10.1016/j.drudis.2012.01.024 Document Type: Editorial

Times cited : (8)

References (10)

1
- 0037428429
- Toward evidence-based health claims for foods
- M.B. Katan, and N.M. de Roos Toward evidence-based health claims for foods Science 299 2003 206 207
- (2003) Science , vol.299 , pp. 206-207
- Katan, M.B.¹ De Roos, N.M.²

2
- 43049180323
- Why have antioxidants failed in clinical trials?
- S.R. Steinhubl Why have antioxidants failed in clinical trials? Am. J. Cardiol. 101 2008 14D 19D
- (2008) Am. J. Cardiol. , vol.101
- Steinhubl, S.R.¹

3
- 0031024171
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
- C.A. Lipinski Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 23 1997 3 25
- (1997) Adv. Drug Deliv. Rev. , vol.23 , pp. 3-25
- Lipinski, C.A.¹

4
- 34447257725
- Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis
- M.C. Wasko Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis J. Am. Med. Assoc. 298 2007 187 193
- (2007) J. Am. Med. Assoc. , vol.298 , pp. 187-193
- Wasko, M.C.¹

5
- 84860657994
- Arthritis drug success with Alzheimer's prompts calls for more investment in research
- C. Paddock Arthritis drug success with Alzheimer's prompts calls for more investment in research Med. News Today April 11 2008
- (2008) Med. News Today , vol.11 APRIL
- Paddock, C.¹

6
- 0000593527
- Studies on the hemorrhagic sweet clover disease. V. Identification and synthesis of the hemorrhagic agent
- M.A. Stahmann Studies on the hemorrhagic sweet clover disease. V. Identification and synthesis of the hemorrhagic agent J. Biol. Chem. 138 1941 513 527
- (1941) J. Biol. Chem. , vol.138 , pp. 513-527
- Stahmann, M.A.¹

7
- 1542343914
- From viper's venom to drug design: Treating hypertension
- M. Patlak From viper's venom to drug design: treating hypertension FASEB J. 18 2004 421E
- (2004) FASEB J. , vol.18
- Patlak, M.¹

8
- 70350322267
- The co-encapsulated antioxidant nanoparticles of ellagic acid and coenzyme Q10 ameliorate hyperlipidemia in high fat diet fed rats
- D.V. Ratnam The co-encapsulated antioxidant nanoparticles of ellagic acid and coenzyme Q10 ameliorate hyperlipidemia in high fat diet fed rats J. Nanosci. Nanotechnol. 9 2009 6741 6746
- (2009) J. Nanosci. Nanotechnol. , vol.9 , pp. 6741-6746
- Ratnam, D.V.¹

9
- 34547700397
- Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: Can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy?
- D.D. Ankola Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: Can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy? Eur. J. Pharm. Biopharm. 67 2007 361 369
- (2007) Eur. J. Pharm. Biopharm. , vol.67 , pp. 361-369
- Ankola, D.D.¹

10
- 67651155772
- The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial
- S. Kim The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial Biomaterials 30 2009 4743 4751
- (2009) Biomaterials , vol.30 , pp. 4743-4751
- Kim, S.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.